2007


VAX Bulletin on AIDS Vaccine Research / IAVI Report

VAX is the bulletin on AIDS vaccine research and news intended for a broad audience, ranging from policymakers and community leaders to advocates and vaccine trial volunteers. Each issue features a collection of articles written in an easily-accessible style allowing non-technical readers to understand the latest developments in the science and policy of AIDS vaccine research.

The Vax bulletin is available in English (HTML and PDF), Chinese (PDF), Deutsch (PDF),
Français (PDF), Español (PDF), and Português (PDF).

-->
VAX 2007 Nov; 5(11)           
  • SPOTLIGHT: Cooking up vaccines
  • GLOBAL NEWS: New HIV/AIDS estimates released
  • PRIMER: Understanding Replicating Viral Vectors: What are the advantages of using replicating viral vectors in AIDS vaccine research?

VAX 2007 Oct/Nov; 5(10)              
  • SPOTLIGHT: A STEP back?
  • CONFERENCE COVERAGE: Giving it their best shot
  • GLOBAL NEWS: Removing the blindfold
  • GLOBAL NEWS: Global HIV Vaccine Enterprise appoints executive director
  • GLOBAL NEWS: New funding focuses on innovation in global health
  • PRIMER: Understanding Randomized, Controlled Clinical Trials: What are randomized, controlled, double-blind clinical trials?

VAX 2007 Sep; 5(9)              
  • SPOTLIGHT: HIV prevalence estimates: Fact or fiction?
  • GLOBAL NEWS: Innovation funding announced for AIDS vaccine research
  • VAX SPECIAL REPORT: What immediate implications does the cessation of immunizations in the STEP trial have for the AIDS vaccine field?

VAX 2007 Aug; 5(8)              
  • SPOTLIGHT: Are two really better than one?
  • GLOBAL NEWS: Researchers establish new enrollment criteria for African volunteers
  • GLOBAL NEWS: AVAC receives grant to advocate for HIV prevention research
  • PRIMER: Understanding Immunogenicity: How do researchers measure the immune responses induced by AIDS vaccine candidates?

VAX 2007 Jul; 5(7)              
  • SPOTLIGHT: Moving target
  • GLOBAL NEWS: Study shows contraceptive diaphragm does not help prevent HIV infection
  • GLOBAL NEWS: India revises HIV/AIDS estimates
  • PRIMER: Understanding HIV Incidence: Why are HIV incidence rates important for AIDS vaccine trials?

VAX 2007 Jun; 5(6)              
  • SPOTLIGHT: Spreading the word
  • GLOBAL NEWS: New AIDS envoy appointed
  • GLOBAL NEWS: Phase I AIDS vaccine trial begins
  • PRIMER: Understanding Data Safety Monitoring Boards: How do DSMBs monitor ongoing clinical trials?

VAX 2007 May; 5(5)              
  • SPOTLIGHT: Deadly duo
  • GLOBAL NEWS: AIDS vaccine trial begins in US
  • GLOBAL NEWS: South Africa launches AIDS plan
  • GLOBAL NEWS: 10th annual World AIDS Vaccine Day commemorated
  • PRIMER: Understanding Partially Effective AIDS Vaccines: What is a partially effective vaccine and how can it limit the spread of HIV?

VAX 2007 Apr; 5(4)              
  • SPOTLIGHT: Keeping talent at home
  • GLOBAL NEWS: Guidelines for male circumcision issued
  • PRIMER: Understanding the Challenges of AIDS Vaccine Development: What are the major scientific obstacles to the development of an effective AIDS vaccine?

VAX 2007 Mar; 5(3)              
  • SPOTLIGHT: The red carpet rolls out at CROI
  • GLOBAL NEWS: Therapeutic vaccine trial shows no benefit
  • GLOBAL NEWS: Canada launches new HIV vaccine development program
  • PRIMER: Understanding Why an Effective AIDS Vaccine is Feasible: What evidence exists for immune control of HIV/SIV?

VAX 2007 Feb; 5(2)              
  • SPOTLIGHT: Testing a new model
  • GLOBAL NEWS: Two new preventive AIDS vaccine trials initiated in Africa
  • PRIMER: Understanding Neutralizing Antibodies: Why are HIV-specific neutralizing antibodies so difficult to induce with vaccination?

VAX 2007 Jan; 5(1)           
  • SPECIAL ISSUE — 2006: YEAR IN REVIEW — This Special Issue of VAX provides a review of AIDS vaccine clinical trial activity in 2006 and a comprehensive listing of all ongoing trials as of January 2007. Last year 13 new trials of preventive AIDS vaccine candidates started in 8 countries around the world. All were either Phase I or Phase I/II trials designed to evaluate the safety and immunogenicity of the candidate vaccines. The Russian Federation began its first AIDS vaccine trial and three countries in sub-Saharan Africa—Kenya, Uganda, and Tanzania—initiated new trials. The map on the inside pages of this issue focuses on these trials as well as countries that started trials in 2003-2005 that are still ongoing. The accompanying table provides information on all ongoing preventive AIDS vaccine trials. For more information, visit the Database of AIDS Vaccine Trials. Please email any additions, comments, or updates to iavireport@iavi.org.


Click on Map of 2006 AIDS Vaccine Trials
to Open/Download PDF (5,672 KB)

IAVI Report

IAVI Report is a publication on international AIDS vaccine research published bi-monthly by the International AIDS Vaccine Initiative (IAVI).

IAVI Report 2007 Sep/Dec; 11(5)
  • Conference Coverage: Giving It Their Best Shot
  • Special Report: 'Stopping a Steam Train'
  • Getting It Right Early
  • What Next?
  • A STEP Back?
  • Vaccine Briefs
IAVI Report 2007 Jul/Aug; 11(4) 
  • HIV Prevalence Estimates: Fact or Fiction?
  • HIV Down Under
  • Reproducing Protection
  • Seattle Sound
  • Balancing Act
  • Vaccine Briefs
IAVI Report 2007 May/Jun; 11(3)
  • Moving Targets
  • Perspective: HIV Controllers: Can the Human Genome Project Advance AIDS Vaccine Development?
  • One-Two Combination
  • Vaccine Briefs
IAVI Report 2007 Mar/Apr; 11(2)
  • Groundhog Day
  • Going Public
  • Meeting Summary: Optimizing HIV Prevention Research
  • Vaccine Briefs

IAVI Report 2007 Jan/Feb; 11(1)
  • And the Winner Is... HIV Treatment and Prevention
  • Molecular Snapshots from CROI 2007
  • An Interview with Dennis Burton
  • Meeting Summary: Advisory Panel Considers Complexities of HIV Prevention Trials
  • In Memoriam: Professor Job Bwayo
  • In Memoriam: Dr. Kenneth Anthony Kalanyi Kebba
  • Vaccine Briefs
This information is designed to support, not replace, the relationship that exists between you and your doctor.
©2007. AEGiS.